Pediatrics Doctors in Logan, UT Accepting Medicare

11 Pediatrics doctors found. Showing 1 - 11

Nordell T Brown, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1940

Russel T Mckenna, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1325 N 600 E Ste 101, Logan, UT 84341 Phone: 435-750-5599    Fax: 435-750-0861

Prafulla Martin-garg, MD, FAAP Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1940

Scott D Dickson, D.O. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-1820    Fax: 435-716-1693

John Dennis Odell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1940

Cason James Wortley, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 2245 N 400 E Ste 202, Logan, UT 84341 Phone: 435-753-7337

Daniel M Sandgren, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1940

Austin Joe Bowles, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1692

Timothy M Anderson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1940

Dr. Matt N Rogers, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1627

Derrel W Clarke, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-792-1940    Fax: 435-792-1692

News Archive

MAKO Surgical second-quarter total revenue increases 151% to $10.3 million

MAKO Surgical Corp., a medical device company that markets both its RIO® Robotic Arm Interactive Orthopedic surgical platform and proprietary RESTORIS® implants for minimally invasive orthopedic knee procedures known as MAKOplasty®, today announced its operating results for its second quarter ended June 30, 2010.

Debate previews: What to watch for in style and substance on health care questions

News outlets predict that health issues - including GOP presidential hopeful Mitt Romney's plan for pre-existing condition coverage - will play a role in tonight's debate.

Purdue and Mundipharma assume worldwide development for Infinity's fatty acid amide hydrolase program

Infinity Pharmaceuticals, Inc. today announced that Purdue Pharmaceutical Products L.P. and its independent associated company, Mundipharma International Corporation Ltd., have exercised their right to assume worldwide development and commercialization activities for Infinity's fatty acid amide hydrolase, or FAAH, program. The decision reflects progress made in the development of Infinity's oral FAAH inhibitor, IPI-940.

Australian TGA approves GI Dynamics EndoBarrier Gastrointestinal Liner for type 2 diabetes and obesity

GI Dynamics, Inc., a company focused on the development and commercialization of effective, non-surgical approaches for the treatment of type 2 diabetes and obesity, today announced that the Australian Therapeutic Goods Administration (TGA) has approved the EndoBarrier® Gastrointestinal Liner for inclusion on the Australian Register of Therapeutic Goods (ARTG).

Read more Medical News

› Verified 7 days ago